According to Ness, the success of HeartFlow’s IPO reflects the market validation of the overall rationale for using AI in ...

By Rishab Shaju and Ateev Bhandari (Reuters) -Medtech firm Heartflow was valued at $2.27 billion on Friday, with its shares ...

HeartFlow’s AI-based CAD platform targets a large market with strong adoption, but IPO valuation and risks warrant caution.

Heartflow (NASDAQ: HTFL) stock surges ~50% as the company focused on AI-driven tools for the diagnosis of heart diseases make ...

Heartflow announced today that it closed its upsized initial public offering (IPO) with proceeds totaling approximately $364.2 million.

Heartflow said it would have about 79.5 million shares outstanding after the IPO, assuming an exercise of the overallotment option, for a market capitalization topping $1.27 billion at the $16-a-share ...

Shares of Heartflow opened at $28 on Friday, jumping over 47% above the initial public offering price of $19 per share in their Nasdaq debut. This opening price valued the medical technology company ...

J.P. Morgan, Morgan Stanley and Piper Sandler acted as joint book-running managers for the offering. Stifel and Canaccord Genuity acted as co-managers for the offering.

The stock of medical imaging and diagnostics software company Heartflow jumped 50% in its market debut on Aug. 8; the latest ...

HeartFlow joins a group of medtechs planning to go public in 2025, including Medtronic’s new standalone diabetes business and ...

Heartflow, backed by private investment firm Bain Capital, said on Wednesday it was targeting a valuation of up to $1.46 ...

(Reuters) -Heartflow shares surged 47.4% in their Nasdaq debut on Friday, giving the medtech firm a valuation of $2.27 billion, as the IPO market gathers momentum and outrides tariff worries. The ...